Representative Josh Gottheimer (Democratic-New Jersey) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on March 16th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on February 5th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.
Representative Josh Gottheimer also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Infineon Technologies (OTCMKTS:IFNNY) on 2/27/2026.
- Sold $1,001 – $15,000 in shares of Palo Alto Networks (NASDAQ:PANW) on 2/27/2026.
- Purchased $1,001 – $15,000 in shares of Federal Signal (NYSE:FSS) on 2/26/2026.
- Sold $1,001 – $15,000 in shares of Intuit (NASDAQ:INTU) on 2/20/2026.
- Sold $1,001 – $15,000 in shares of Carvana (NYSE:CVNA) on 2/18/2026.
- Sold $1,001 – $15,000 in shares of Visa (NYSE:V) on 2/18/2026.
- Purchased $1,001 – $15,000 in shares of Cummins (NYSE:CMI) on 2/5/2026.
- Purchased $1,001 – $15,000 in shares of GE Vernova (NYSE:GEV) on 2/5/2026.
- Purchased $1,001 – $15,000 in shares of Exxon Mobil (NYSE:XOM) on 2/4/2026.
- Sold $1,001 – $15,000 in shares of Fair Isaac (NYSE:FICO) on 2/4/2026.
UnitedHealth Group Trading Down 0.7%
NYSE:UNH traded down $1.80 during mid-day trading on Wednesday, hitting $270.48. 8,021,975 shares of the company’s stock were exchanged, compared to its average volume of 9,907,906. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36. The company has a 50 day simple moving average of $294.53 and a 200-day simple moving average of $323.80. The firm has a market capitalization of $245.51 billion, a P/E ratio of 20.51, a PEG ratio of 1.24 and a beta of 0.41.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 67.02%.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of UNH. Brighton Jones LLC raised its holdings in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its stake in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the period. CMT Capital Markets Trading GmbH bought a new position in UnitedHealth Group in the second quarter worth approximately $340,000. Cetera Investment Advisers raised its position in shares of UnitedHealth Group by 6.4% during the second quarter. Cetera Investment Advisers now owns 263,248 shares of the healthcare conglomerate’s stock worth $82,125,000 after purchasing an additional 15,866 shares during the period. Finally, Avantax Advisory Services Inc. lifted its holdings in shares of UnitedHealth Group by 11.2% in the 2nd quarter. Avantax Advisory Services Inc. now owns 77,338 shares of the healthcare conglomerate’s stock worth $24,127,000 after purchasing an additional 7,818 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
UNH has been the topic of several recent research reports. JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating on the stock in a report on Monday, February 2nd. Truist Financial lowered their price objective on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, February 2nd. Oppenheimer decreased their target price on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Leerink Partners dropped their price target on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Finally, Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $372.13.
Read Our Latest Stock Analysis on UNH
About Representative Gottheimer
Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027.
Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2026 election.
Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025.
Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Recommended Stories
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
